| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oruka Therapeutics, Inc. (ORKA) has 8 insiders with recent SEC Form 4 filings, including 4 buys and 7 sells. ORKA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.13M | $73.24M | - | |
| COO | 206.2K | $13.34M | - | |
| Other | 36.1K | $2.34M | -7,000 | |
| Dir | 35.0K | $2.26M | - | |
| Dir | 17.5K | $1.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2020 | Conway Robert E | Director, Chairman Of The Board | Buy | 10,000 | $4.16 | $41,630.00 | +50.0% | |
| Sep 25, 2020 | Conway Robert E | Director, Chairman Of The Board | Buy | 5,000 | $4.28 | $21,399.50 | +33.3% | |
| Sep 22, 2020 | Conway Robert E | Director, Chairman Of The Board | Buy | 3,056 | $4.66 | $14,240.65 | +25.6% | |
| Sep 21, 2020 | Conway Robert E | Director, Chairman Of The Board | Buy | 10,000 | $4.77 | $47,660.00 | +514.4% | |
| Apr 3, 2018 | Keuer Thomas A | Chief Operating Officer | Sell | 482 | $0.50 | $241.72 | -3.5% | |
| Apr 2, 2018 | Selby Brian L. | VP, Finance | Sell | 1,114 | $0.50 | $556.33 | -100% | |
| Feb 28, 2018 | Keuer Thomas A | Chief Operating Officer | Sell | 410 | $0.72 | $294.38 | -2.9% | |
| Feb 27, 2018 | Selby Brian L. | VP, Finance | Sell | 161 | $0.53 | $85.33 | -12.6% | |
| Feb 27, 2018 | Venrock Healthcare Capital Partners LP | 10% Owner | Sell | 1,541,331 | $0.55 | $846,905.43 | -97.4% | |
| Feb 26, 2018 | Sakoda Jon | 10% Owner | Sell | 1,460,209 | $0.50 | $731,272.67 | -100% |